IMNM — Immunome, Inc. stock price, charts and financials

QT58Immunome, Inc.

Immunome, Inc. (NASDAQ: IMNM) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
25.06
+2.05+8.91%
IMNMQT58Immunome, Inc.·NASDAQ
25.06+8.91%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 27, 20264Statement of changes in beneficial ownership
Jul 09, 20264Statement of changes in beneficial ownership
Jul 07, 20264Statement of changes in beneficial ownership
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 09, 20264Statement of changes in beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)